Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2012-04-06
Original SEC Filing: Click here

---

Webplus: SVA/20120406/6-K/2_EX-99.1/000.htm SEC Original: v308765_ex99-1.htm
Sinovac Reports Unaudited Fourth Quarter and Preliminary Full Year 2011 Financial Results – Conference call scheduled for Thursday, March 29, 2012 at 8:00 AM EDT – BEIJING, March 29, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and preliminary full year financial results for the period

---

---

Webplus: SVA/20120406/6-K/1/000.htm SEC Original: v308765_6k.htm
SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v308765_6k.htm 6-K

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2012-04-06CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085